作者: Carolin Tonus
关键词:
摘要: AIM: To evaluate the utility of innovative fecal tumor M2-Pyruvate kinase (M2-PK) test in our daily clinical routine, as a marker for pre-selection patients who should subsequently undergo colonoscopy diagnosis or exclusion colorectal cancer. METHODS: Fecal M2-PK was measured stool samples 96 study participants (33 with cancer, 21 rectal carcinoma and 42 controls) all underwent total colonoscopy. RESULTS: In 39 individuals control group, below 4.0 kU/L (93% specifi city). Colorectal tumors were accompanied by highly significant increase (P < 0.001) M2- PK levels (median: colon carcinoma, 23.1 kU/L; 6.9 14.7 kU/L), which correlated Duke's staging T-classifi cation. The overall sensitivity 78% increasing from 60% stage T1 to 100% T4 A 90% D tumors. CONCLUSION: is an appropriately sensitive tool pre-select those requiring further diagnostic confirmation